Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2008-11-10
pubmed:abstractText
Irinotecan is an active drug in the first and subsequent lines of chemotherapy for patients with advanced colorectal cancer. Frequently, the elderly patients are excluded from receiving irinotecan alone or in combination, and on many occasions these patients receive an initial reduced dose of this drug. This revision has been focused in the role of irinotecan in elderly patients.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1040-8428
pubmed:author
pubmed:issnType
Print
pubmed:volume
68
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
250-5
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
Irinotecan in the treatment of elderly patients with advanced colorectal cancer.
pubmed:affiliation
Medical Oncology Department, San Carlos Hospital, c/Martin Lagos s/n, 28040 Madrid, Spain. giuseppedilorenzoncol@hotmail.com <giuseppedilorenzoncol@hotmail.com>
pubmed:publicationType
Journal Article, Comparative Study, Review